Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pauline A. Mysliwiec"'
Autor:
Joanne E. Schottinger, Douglas A. Corley, Nirupa R. Ghai, Carrie N. Klabunde, Pauline A. Mysliwiec, Virginia P. Quinn, Ann G. Zauber, Christopher D. Jensen, Amy R. Marks, Wei K. Zhao, Alexander T. Lee, Chyke A. Doubeni, Theodore R. Levin, Richard Contreras, Charles P. Quesenberry, Jeffrey Lee
Publikováno v:
Annals of internal medicine. 164(7)
Background The fecal immunochemical test (FIT) is a common method for colorectal cancer (CRC) screening, yet its acceptability and performance over several rounds of annual testing are largely unknown. Objective To assess FIT performance characterist
Autor:
Perry J. Pickhardt, Inku Hwang, Hans A. Hildebrandt, Pauline A. Mysliwiec, J. Richard Choi, William R. Schindler, Roy K.H. Wong, Pamela A. Nugent, James A. Butler, Michael L. Puckett
Publikováno v:
New England Journal of Medicine. 349:2191-2200
background We evaluated the performance characteristics of computed tomographic (CT) virtual colonoscopy for the detection of colorectal neoplasia in an average-risk screening population. methods A total of 1233 asymptomatic adults (mean age, 57.8 ye
Autor:
J. Richard Choi, Pauline A. Mysliwiec, Perry J. Pickhardt, Pamela A. Nugent, William R. Schindler
Publikováno v:
Annals of internal medicine. 141(5)
Previous estimates of the adenoma miss rate with optical colonoscopy (OC) are hindered by the use of OC as its own reference standard.To evaluate the frequency and characteristics of colorectal neoplasms that are missed prospectively on OC by using v
Publikováno v:
American journal of preventive medicine. 25(3)
Background Data on the involvement of nonphysician healthcare providers in colorectal cancer (CRC) screening delivery are sparse. This article describes physicians' use of nurse practitioners and physician assistants to provide CRC screening with the
Publikováno v:
The American journal of medicine. 115(2)
Purpose There is a national goal in the United States to increase the level of colorectal cancer screening, but there is currently little information on resources for the delivery of endoscopic screening and follow-up diagnostic and surveillance proc
Autor:
Christopher D. Jensen, Douglas A. Corley, Wei Zhao, Theodore R. Levin, Jeffrey Lee, Pauline A. Mysliwiec, Carrie N. Klabunde
Publikováno v:
Gastroenterology. 146:S-33
One sample quantitative FIT kits (either NS-Plus Chemistry analyzer, Alfresa Pharma Corp., Japan or OC-Sensor DIANA IFOB Test System, Eiken Chemical Company Ltd., Japan) were used. The primary outcome was return of a completed one sample FIT kit. Pat
Autor:
Marjolein van Ballegooijen, Christopher D. Jensen, Pauline A. Mysliwiec, Douglas A. Corley, Jeffrey Lee, Jennifer L. Schneider, Joanne E. Schottinger, Theodore R. Levin, Wei Zhao, Nirupa R. Ghai, Ann G. Zauber, Virginia P. Quinn, Amy R. Marks, Chyke A. Doubeni, Wendy Atkin, Richard Contreras
Publikováno v:
Gastroenterology. 144:S-145
Autor:
Debra R. Maurer, Steven Courteau, Theodore R. Levin, Wei K. Zhao, Pauline A. Mysliwiec, Elaine H. Chung
Publikováno v:
Gastroenterology. 134:A-485
Publikováno v:
Annals of Internal Medicine. 141:264
Increasing use of colonoscopy for colorectal cancer screening and surveillance of colorectal adenomas after polypectomy has given rise to concerns about the availability of endoscopic resources in the United States. Guidelines recommend surveillance